Illumina-JPM-Conference-January-2026.pdf

1、 2026 Illumina,Inc.All rights reserved.Jacob Thaysen,PhDChief Executive Officer44th Annual J.P.MorganHealthcare Conference 2026 Illumina,Inc.All rights reserved.January 13,2026 2026 Illumina,Inc.All rights reserved.J.P.Morgan Healthcare Conference 2026This release may contain forward-looking stateme

2、nts that involve risks and uncertainties.Among the important factors to which our business is subject that could cause actual results to differ materially from those in any forward-looking statements are:Our ability to meet our revenue and earnings per share growth targets;Changes in the rate of gro

3、wth in the markets we serve;The volume,timing and mix of customer orders among our products and services;Our ability to adjust our operating expenses to align with our revenue expectations;Our ability to manufacture robust instrumentation and consumables;The success of products and services competit

4、ive with our own;Challenges inherent in developing,manufacturing,and launching new products and services,including expanding or modifying manufacturing operations and reliance on third-party suppliers for critical components;The impact of recently launched or pre-announced products and services on e

5、xisting products and services;Our ability to realize the anticipated benefits from prior or future actions to streamline and improve our R&D processes,reduce our operating expenses and maximize our revenue growth;To deploy new products,services,and applications,and to expand the markets for our tech

6、nology platforms;Our ability to obtain approval by third-party payors to reimburse patients for our products;Our ability to obtain regulatory clearance from applicable government agencies for our acquisition of SomaLogic and certain of our products;Our ability to successfully partner with other comp